CI Collaborates with NHFC

CI Collaborates with NHFC

Late on the night of September 23rd, Clifford Carnicom, founder and president of Carnicom Institute, set out by train from Spokane, Washington to attend the 2014 United States Health Freedom Congress in St. Paul Minnesota. He was invited by Diane Miller, JD, Director of Law and Public Policy for the National Health Freedom Coalition (NHFC), and the National Health Freedom Action. These organizations bring together leaders from across the country who are working toward health freedoms and the legislation which can secure these freedoms for people in the United States. Clifford was honored to be invited and to offer a view of his work to people unfamiliar with it. At the same time, he was eager to learn about the work of the other members. I interviewed Clifford upon his return.
Statement of Intent and Planning

Statement of Intent and Planning

I have the responsibility to provide a certain level of detail regarding the planned research and operations for Carnicom Institute during the upcoming year. The primary issue of discussion is the balance between active research and the presentation of that same research to the public. The current situation is that the pace of research during the first half of this year has exceeded the capabilities of the Institute to present and disclose the results of that same research to the public. It is something to be grateful for that such a body of work is in place. The situation is not problematic but the lag is probably on the order of four to six months of work at this time. This dilemma will force certain decisions to be made as to what must be sacrificed with the available resources to achieve the greatest good. The immediate instinct is often to pursue the research needs in the most earnest fashion, as discoveries of some type occur on almost every day of business within this laboratory and associated work. Some of these discoveries are compelling and profound from a scientific standpoint, but the scientific methods demand that such fascinations be held in reserve until they are reliably replicated over a period of time. This is the nature of the work and this has always been the case; however, we must also not assume that infinite time for review and deliberation of our questions and discoveries remain.
Biofilm, CDB and Vitamin C

Biofilm, CDB and Vitamin C

A method has been established that shows promise of being effective in removing significant masses of biofilm that encapsulate large quantities of the "cross-domain bacteria" (CDB) as they have been identified and designated by this researcher. This method applies to oral cavities only and it is simple to investigate as to its efficacy. The identification of the CDB has been confirmed by microscopy; one unique feature of this organism is the frequent co-linear arrangement of the bacteria within an encasing filament. The various stages of growth of this life form have been documented extensively on this site, and a progression of development is understood. The term "Morgellons" as popularly used, is insufficient to characterize both the uniqueness of the life form and its ubiquity in the environment. The term "cross-domain bacteria" (i.e., CDB) has been established as being intrinsic to the origin of the life form; attention has been called to the the fact that the scientific nomenclature for this 'new biology' remains woefully inadequate. Any perception that this so-called "condition" is restricted to the human species is false; planetary consequences are before us. Please refer to earlier discussions that elevate the seriousness of this need for increased participation by the scientific and health communities.